Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
about
Continuing the paradigm shift in the treatment of idiopathic membranous nephropathy.Primary IgA nephropathy: current challenges and future prospects.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up.
P2860
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Safety of Rituximab Compared w ...... pathic Membranous Nephropathy.
@en
type
label
Safety of Rituximab Compared w ...... pathic Membranous Nephropathy.
@en
prefLabel
Safety of Rituximab Compared w ...... pathic Membranous Nephropathy.
@en
P2093
P2860
P50
P356
P1476
Safety of Rituximab Compared w ...... pathic Membranous Nephropathy.
@en
P2093
Antonietta Chianca
Barbara Ruggiero
Jack F M Wetzels
Jan A J G van den Brand
Julia M Hofstra
P2860
P304
P356
10.1681/ASN.2016091022
P577
2017-05-09T00:00:00Z